BLACK FRIDAY20% OFF EVERYTHINGSAME-DAY EU DISPATCHENDS 30 NOVEMBER

What Is BPC-157? Pentadecapeptide Peptide Research Overview

Lab guide · Tissue & thymic peptides

What Is BPC-157? Pentadecapeptide Peptide Research Overview

What is BPC-157? It is a synthetic 15-amino-acid peptide described as part of a protein found in gastric juice, studied almost entirely in cell and rodent models. This guide covers its structure, the pathways reported in published work, what the evidence does and does not show, and how it is handled in the lab.

Baltic Peptides lab team8 min readUpdated 22 November 2026

FAQ

Common questions

What is BPC-157?
A synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV) described as a partial sequence of a protein found in gastric juice. It is studied almost entirely in cell and rodent models.
What is the amino acid sequence of BPC-157?
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, written GEPPPGKPADDAGLV. It has a free N-terminus and a free C-terminal acid, and contains no cysteine, methionine or tryptophan.
What is the molecular weight and CAS number of BPC-157?
The formula is C62H98N16O22 and the average molecular weight is about 1419.5 g/mol, with a monoisotopic mass of 1418.704 Da. PubChem lists CAS number 137525-51-0 for the free peptide.
Who discovered BPC-157 and when?
Predrag Sikiric and colleagues described it in the early 1990s. A 2025 systematic review dates the first description to 1992 and found published studies from 1993 to 2024.
Is BPC-157 the same as TB-500?
No. BPC-157 is a 15-residue peptide derived from a gastric protein, while TB-500 is a name used in the research market for thymosin beta-4 or a fragment of it. They differ in sequence, size and the pathways studied.
Is there human clinical evidence for BPC-157?
Almost none. A 2025 systematic review found 35 preclinical studies and one retrospective clinical report of 12 patients, and it found no human safety data.
Is BPC-157 approved as a medicine?
No. The 2025 systematic review reports no FDA-approved indication, an FDA Category 2 bulk-substance designation in 2023 and a specific WADA prohibition. Baltic Peptides supplies it for laboratory research only.
What does a BPC-157 certificate of analysis show?
A batch COA reports HPLC purity and a mass-spectrometry identity check, where the intact peptide should appear near 1419.5 Da (about 1419.71 for the [M+H]+ ion). Baltic Peptides publishes batch reports on its COA page.

Keep reading

Related reading

BPC-157

Current batches, formats and the COA for BPC-157.

What is TB-500?

How thymosin beta-4 research differs from BPC-157 studies.

Peptide blends explained

Why component research does not define a combined formulation.

Research-grade BPC-157, tested before it ships

Independent HPLC and mass spec results for every batch, dispatched from the EU.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
0